Clinical trials
Recruiting Phase 3 Uterine Cervical Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Bovax Biotechnology Co., Ltd. | 2 |
| Fourth Affiliated Hospital of Guangxi Medical University | 1 |
| Hospital do Coracao | 1 |
| Huazhong University of Science and Technology | 1 |
| Institut Claudius Regaud | 1 |
| Lee's Pharmaceutical Limited | 1 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 1 |
| Mahidol University | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Peking Union Medical College Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 19 |
| Condylomata Acuminata | 2 |
| Vaginal Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Carcinoma, Adenosquamous | 1 |
| Genital Neoplasms, Female | 1 |
| Neoplasms | 1 |
| Neoplasms by Site | 1 |
| Papillomavirus Infections | 1 |
| Urogenital Neoplasms | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.